Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

104.39
Delayed Data
As of Feb 26
 -2.27 / -2.13%
Today’s Change
47.03
Today|||52-Week Range
111.49
+7.62%
Year-to-Date

Today’s Trading

Previous close106.66
Today’s open106.36
Day’s range102.38 - 106.90
Volume403,086
Average volume (3 months)709,371
Market cap$8.9B
Dividend yield--
Data as of 4:00pm ET, 02/26/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+35.70%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book8.79

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.08-0.12%
ISISIsis Pharmaceuticals...-0.82-1.20%
ICLRICON PLC+1.69+2.49%
CRLCharles River Labora...-0.03-0.04%
Data as of 4:04pm ET, 02/26/2015

Financials

Next reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account